Onyx is a specialist agency with a laser focus on orphan drugs/rare diseases, regenerative medicine including gene therapy, biosimilars and innovative medical technologies where significant unmet clinical needs exist.
Building on our deep heritage in orphan drugs/rare diseases and regenerative medicines, Onyx delivers engaging made-to-measure programmes which successfully overcome the significant and very specific communications challenges such areas present.
Onyx reflects our ability to navigate complex science and our commitment to developing communications for therapies at the cutting edge of medicine using a mix of traditional channels, exciting new innovations in the digital space and avant-garde creativity.
Howard Sinclair presenting at the Cell Therapy Manufacturing & Gene Therapy Congress in Brussels earlier this year, a particular honour for the Onyx team.
We’re always looking for brilliant people to join our teams! Click the link to find out more about becoming part of Prime Global, view available roles, and apply.
An estimated 350 million people worldwide have a rare disease and 30% of children with rare diseases die before their 5th birthday.* Thirty-five percent of deaths in the first year of life are caused by rare diseases.*
*Source: www.globalgenes.org
This World AIDS Day, Emma Sutcliffe, SVP Patient Insights and Solutions, takes a look at how far we’ve come and how far we’ve yet to go. Patient activism is a key factor in this progression; Emma discusses her experiences over a near-three-decade career in medical communications and working with patient organisations and how central the patient really is.
read more >>
In recognition of Lung Cancer Awareness Month, Olivia Kersey, Patient Engagement Strategist, illustrates current opportunities for the pharmaceutical industry to better meet lung cancer patients’ needs across clinical trials and beyond.
read more >>
Patient involvement in clinical trial design has evolved to provide opportunity for patients to be involved in medical publications. This evolution has allowed medical publications to gain invaluable patient perspectives on clinical research, by involving patients as authors in the development of plain language summaries and other, more traditional types of research publications1.
read more >>Use the contact form or get full details for each of our offices around the world.